Origin Asset Management’s Elevance Health ELV Stock Holding History

Origin Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,000	Closed	-$1.91M	–	65
2021 Q2	$1.91M	Hold	5,000	–	–	0.21%	42
2021 Q1	$1.79M	Sell	5,000 -200	-4%	-$64.3K	0.18%	49
2020 Q4	$1.67M	Hold	5,200	–	–	0.16%	54
2020 Q3	$1.4M	Sell	5,200 -1,400	-21%	-$377K	0.15%	54
2020 Q2	$1.74M	Sell	6,600 -500	-7%	-$133K	0.25%	50
2020 Q1	$1.61M	Sell	7,100 -14,050	-66%	-$3.83M	0.21%	55
2019 Q4	$6.39M	Sell	21,150 -7,200	-25%	-$1.98M	0.53%	52
2019 Q3	$6.81M	Sell	28,350 -2,500	-8%	-$685K	0.62%	47
2019 Q2	$8.71M	Sell	30,850 -19,500	-39%	-$5.33M	0.97%	37
2019 Q1	$14.4M	Buy	50,350 +3,150	+7%	+$911K	1.21%	34
2018 Q4	$12.4M	Sell	47,200 -8,600	-15%	-$2.36M	1.13%	40
2018 Q3	$15.3M	Buy	+55,800	New	+$14.5M	1%	45

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Origin Asset Management's ELV Position: Q3 2021 in Review

Origin Asset Management sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 5,000 shares — an estimated $1.91M sold.

Origin Asset Management first reported a position in ELV in Q3 2018 and held it in 12 quarters. The position peaked at $15.3M in Q3 2018. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Origin Asset Management reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
Origin Asset Management sold 5,000 Elevance Health shares in Q3 2021, an estimated $1.91M.
Origin Asset Management first reported a position in Elevance Health in Q3 2018 and held it in 12 quarters.
Origin Asset Management's Elevance Health position peaked at $15.3M in Q3 2018.
1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Origin Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.